HIPEC surgery and blood flow monitoring
Part of Cancer, Heart & circulation clinical trials.
This trial studies how HIPEC surgery, which combines surgery to remove tumors in the abdomen with heated chemotherapy, affects blood flow and heart function. It may help doctors better manage patients during and after this complex procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to have cytoreductive surgery with HIPEC.
- You are in ASA physical class II, III, or IV (a measure of your overall health).
- Your surgery is not an emergency case.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the body’s heat changes during HIPEC surgery for abdominal cancer. It may help improve how doctors plan and deliver HIPEC in the future.
This trial looks at whether a heated chemotherapy treatment given in the abdomen during a planned second surgery (HIPEC) can improve outcomes for certain advanced ovarian cancers. It is for people who have already had initial chemotherapy and partially responded, with enough health to safely undergo surgery.
This early-phase study tests whether a treatment called HIPEC is safe and feasible in people with high-risk gallbladder adenocarcinoma after surgery. HIPEC delivers chemotherapy directly into the abdomen during the operation to lower the chance of cancer coming back.
This study is an audit (a review of care) of patients who undergo cytoreductive surgery plus heated chemotherapy placed in the abdomen. It helps doctors understand how this treatment is done and what outcomes and safety it has.
This study looks at adding a heated medicine treatment (HIPEC with mitomycin C) during surgery to treat colon cancer that has spread to the lining of the abdomen (peritoneum). It aims to improve outcomes after surgeons remove visible tumor completely.
This study tests a treatment that uses heated chemotherapy directly in the belly (called hyperthermic intraperitoneal treatment) combined with an immunotherapy drug to see if it can make the immune therapy work better for advanced ovarian cancer.
Hear when a new Hemodynamics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.